RecruitingNCT07267871
Oura Blood Pressure Profile Study
Oura Blood Pressure Profile Study: An Evaluation of the Oura Blood Pressure Profile Algorithm for Identifying Signs of Hypertension
Sponsor
Ouraring Inc.
Enrollment
2,000,000 participants
Start Date
Dec 17, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.
Eligibility
Min Age: 22 Years
Inclusion Criteria6
- Located in United States
- Aged 22 years or older at time of eligibility screener
- Oura Ring user (Oura Ring Gen3 or newer)
- User of the English version of the Oura App
- Smartphone (iOS or Android) user
- Able to provide consent electronically
Exclusion Criteria3
- User of implanted cardiac electronic device(s)
- Currently pregnant
- Within 12 weeks postpartum
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07267871
Related Trials
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
Genetics of Type 2 Diabetes in West Africans
NCT008371225 locations
Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.
NCT037624991 location
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731152 locations
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT061870121 location